tirzepatide ema Why I Take Low-Dose (Zepbound) – Dr Brad Stanfield EMA 2025: 38 Novel Drugs

Beyond the headline weight loss numbers, the metabolic improvements observed in participants paint an encouraging picture of overall health benefits

However, its important to understand some key points: Mounjaro is FDA-approved for type 2 diabetes Although promising results have been observed in studies regarding weight management, FDA approval for this specific use has not yet been granted

Human support is strong once youre in the system, but getting answers before youre in the system is harder than it should be

Contact your GP, prescribing clinician, or clinical trial team if: Cold feelings are persistent, worsening, or significantly affecting your quality of life You notice cold sensations accompanied by unusual fatigue, pallor, shortness of breath, or dizziness , which may suggest anaemia your GP can arrange a Full Blood Count (FBC) and ferritin level to investigate You experience cold, numb, or discoloured fingers and toes (particularly white, blue, or red colour changes), which could indicate Raynaud's phenomenon a condition affecting blood flow to the extremities (NHS) You have unexplained hair loss alongside cold intolerance , which may point to thyroid dysfunction a Thyroid Function Test (TFT) can be arranged by your GP Cold feelings develop alongside significant muscle weakness or cramps , which could suggest an electrolyte imbalance your GP can arrange Urea and Electrolytes (U&Es) and other relevant blood tests You experience persistent vomiting, diarrhoea, or an inability to keep fluids down , as these can lead to dehydration and, in some cases, acute kidney injury (AKI) seek prompt medical review if you notice reduced urine output or feel faint If you are enrolled in a clinical trial , contact your study team before making any changes to your treatment or if you develop new or worsening symptoms